BC Mandatory Switching to Biosimilar
British Columbia has become the first public payer to implement a mandatory switching policy that is expected to dramatically increase the use of biosimilars in the province.
READ MORE… BC sets precedent with mandatory switching to Biosimilar
Prescription Drug Update
On December 1, 2017 the Canadian Federal Ministry of Health proposed changes to the drug pricing regulations in an effort to protect Canadians from current and future excessive drug costs. Believe it or not, Canadians are spending more per capita on drugs than any other country in the world except for the US!
READ MORE…Prescription Drugs Update from HRS – February 28, 2018
